Welcome to Maruf "PGx-K2A" Lab at the
University of Manitoba College of Pharmacy!
University of Manitoba College of Pharmacy!
The overarching aim of Dr. Maruf's research program (Pharmacogenomics Knowledge to Action - "PGxK2A Lab") is to facilitate the development, evaluation, and implementation of evidence-informed precision medicine initiatives using quantitative and qualitative methodologies and implementation science techniques. Our lab conducts cutting-edge research to bring clinical innovation into practice by reducing the knowledge-to-practice gap. Our research program is collaborative and follows a teacher-scholar model that involves scholarly activities with students from various levels, innovative teaching approaches, and service activities to the institution, the profession, and the society.
Current research priorities:
- Pharmacogenomic and pharmacovigilance studies to understand inter-individual variation in medication response.
- Patient-oriented research to optimize precision health/medicine tools for diverse populations.
- Knowledge translation, implementation, and educational research to help expand the scope of pharmacy practice to evidence-based precision medicine.
Our lab is currently the Manitoba site or cohort lead or collaborator on PGx-SParK, Pan-GEM, PrairieGen, CYMH Trials Network, and KINDTrials.
|
Abdullah Al Maruf
B.Pharm, M.Pharm, Ph.D. Assistant Professor College of Pharmacy Rady Faculty of Health Sciences University of Manitoba, Winnipeg, Manitoba Scientist Children’s Hospital Research Institute of Manitoba (CHRIM) Adjunct Assistant Professor Department of Psychiatry Max Rady College of Medicine University of Manitoba, Winnipeg, Manitoba Adjunct Assistant Professor Department of Psychiatry Hotchkiss Brain Institute Cumming School of Medicine University of Calgary, Calgary, Alberta |
Latest Lab News:
May: Dr. Maruf attended the Faculty of Graduate Studies (FGS) 2025 Awards Reception where our PhD student Md. Abdul Aziz received the 2025 Dean of Graduate Studies Student Achievement Award. May: We are excited to welcome Mahin Hasan as our newest group member. Mahin will pursue a PhD in the College of Pharmacy under Dr. Maruf's supervision. May: We are happy to welcome four students for summer research! Thank you to the University of Manitoba Undergraduate Research Awards (URA) and College of Pharmacy PharmD Undergraduate Summer Research Award (COP USRA) programs for supporting these talented students. They received $30,000 fellowships in total. Mar: New Paper Alert! Estimating the Frequency of False-Negative Pharmacogenetic Test Results by Self-Reported Ancestry. Clinical Pharmacology and Therapeutics. Link. Apr: Dr. Maruf appeared on CTV Manitoba to discuss the PGx-SImBA study, the first psychiatric pharmacogenetic study in Manitoba. Watch Apr: Md. Abdul Aziz, our PhD student has received a 2025 AFPC / CCPE Pharmacy Student Research Poster Award. Congratulations Aziz! Mar: We are in the Winnipeg Free Press! Read here: https://www.winnipegfreepress.com/breakingnews/2025/03/21/new-research-explores-genetic-factors-behind-adverse-reactions-to-antidepressants-in-young-canadians Read more LAB NEWS |
We are highly interested in developing collaborations to do amazing science, education, and advocacy.
If you are interested in collaborating, please get in touch with Dr. Maruf.
If you are interested in collaborating, please get in touch with Dr. Maruf.
Dr. Maruf has secured approximately $23 million in peer-reviewed and philanthropic funding as a principal investigator or part of several national research teams. Our research program is funded by the University of Manitoba College of Pharmacy, Rady Faculty of Health Sciences, Department of Psychiatry Academic Projects (DPAP) Award, Kaniz Amina Mannan Research Grant, Health Sciences Centre Foundation (HSCF), Children's Hospital Research Institute of Manitoba (CHRIM), Children's Hospital Foundation of Manitoba, George & Fay Yee Centre for Healthcare Innovation (CHI), Accelerating Clinical Trials Platform (ACT-AEC), Canadian Institute of Health Research (CIHR), and Genome Canada.
|
|
|
|
|
|
|
|